| Certificates/Standards: | N; |
| Monthly Output: | Not provided |
| Regional: | Not provided |
| Packaging Information: | Not provided |
| Mode Of Payment: | Not provided |
| Delivery Lead Time: | Not provided |
| Main Sales Markets: | North America，Central/South America，Western Europe，Eastern Europe，Australasia，Asia，Middle East，Africa |
| Sample Provided: | No |
| Sample Policy: | Not provided |
| Minimum Quantity: | Not provided |
Lactobacillus acidophilus strain L-92™ has been singled out as a strain of Lactobacillus with allergy-relieving effects, over the course of around 100 years of research into CALPIS® Lactobacillus. Lactobacillus acidophilus strain L-92™ has the effect of safely and efficiently relieving allergic symptoms from inside the body. Subsequent research has also indicated that Lactobacillus acidophilus strain L-92™ relieves symptoms of conditions such as hay fever, perennial allergic rhinitis and atopic dermatitis by maintaining a balance between immune cells. Lactobacillus acidophilus strain L-92™ has been granted Self-Affirmed GRAS approval in the US.
沪公网安备31010402001403号
